rs12720854

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000384.3(APOB):​c.9835A>G​(p.Ser3279Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,614,042 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.0076 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 42 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

5
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:17

Conservation

PhyloP100: 3.43
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004425019).
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0515 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
APOBNM_000384.3 linkuse as main transcriptc.9835A>G p.Ser3279Gly missense_variant 26/29 ENST00000233242.5 NP_000375.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
APOBENST00000233242.5 linkuse as main transcriptc.9835A>G p.Ser3279Gly missense_variant 26/291 NM_000384.3 ENSP00000233242 P1

Frequencies

GnomAD3 genomes
AF:
0.00768
AC:
1168
AN:
152174
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.0136
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.00294
Gnomad OTH
AF:
0.0139
GnomAD3 exomes
AF:
0.00431
AC:
1082
AN:
251186
Hom.:
9
AF XY:
0.00400
AC XY:
543
AN XY:
135736
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.00634
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00137
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00799
GnomAD4 exome
AF:
0.00325
AC:
4757
AN:
1461750
Hom.:
42
Cov.:
37
AF XY:
0.00330
AC XY:
2399
AN XY:
727166
show subpopulations
Gnomad4 AFR exome
AF:
0.0184
Gnomad4 AMR exome
AF:
0.00644
Gnomad4 ASJ exome
AF:
0.0102
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00132
Gnomad4 FIN exome
AF:
0.000131
Gnomad4 NFE exome
AF:
0.00247
Gnomad4 OTH exome
AF:
0.00654
GnomAD4 genome
AF:
0.00765
AC:
1165
AN:
152292
Hom.:
8
Cov.:
33
AF XY:
0.00773
AC XY:
576
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.0170
Gnomad4 AMR
AF:
0.0103
Gnomad4 ASJ
AF:
0.0136
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00294
Gnomad4 OTH
AF:
0.0137
Alfa
AF:
0.00451
Hom.:
16
Bravo
AF:
0.00849
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.0154
AC:
68
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00440
AC:
534
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00510

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:17
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Uncertain:3Benign:3
Likely benign, criteria provided, single submitterclinical testingRobarts Research Institute, Western UniversityAug 22, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJul 10, 2015- -
Uncertain significance, criteria provided, single submitterresearchCardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo JorgeMar 01, 20162/96 normolipidaemic Portuguese controls -
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJul 07, 2017- -
Uncertain significance, criteria provided, single submitterresearchLaboratory of Genetics and Molecular Cardiology, University of São PauloMar 01, 2016- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 1.6% (165/10404) African chromosomes -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxApr 15, 2019This variant is associated with the following publications: (PMID: 29172679, 24234650, 26332594, 27153395, 23043354, 27884173, 20657596) -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024APOB: BP4, BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 27, 2023- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoAug 02, 2023- -
Familial hypercholesterolemia Benign:2
Likely benign, no assertion criteria providedclinical testingCohesion PhenomicsFeb 09, 2023- -
Benign, criteria provided, single submitterclinical testingGENinCode PLCJun 21, 2022- -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Familial hypobetalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterSep 22, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 26, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
16
DANN
Uncertain
0.99
Eigen
Uncertain
0.21
Eigen_PC
Benign
-0.0019
FATHMM_MKL
Uncertain
0.95
D
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-0.68
T
MutationTaster
Benign
0.64
N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.26
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.0030
D
Vest4
0.25
MVP
0.68
MPC
0.049
ClinPred
0.058
T
GERP RS
3.4
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12720854; hg19: chr2-21229905; API